MECHANISMS OF COMPLEMENT INDUCED ENDOTHELIAL DYSFUNCTION

补体引起的内皮功能障碍的机制

基本信息

  • 批准号:
    2910613
  • 负责人:
  • 金额:
    $ 30.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-05-01 至 2000-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from the applicant's abstract) There is considerable recent interest in the activation of complement proteins during the early stages of myocardial ischemia and reperfusion. In the present proposal this research team continue their focus on endothelial injury, with particular emphasis on the alternative complement pathway. They provide excellent evidence that hypoxia alone does not activate this cascade; rather, reperfusion and oxygen radicals produce C5b, the linchpin for sequential assembly of the C5b-9 membrane attack complex. This transmembrane pore complex could directly injure vascular endothelium by a number of mechanisms, including production of oxygen metabolites. The role of the C5a fragments is projected to involve synergistic activation of neutrophils compounding vascular injury. The five year proposal consists of experiments investigating complement mechanisms in isolated vessels (both large and micro-vessels, years 1 and 2), verification of complement deposition after hypoxia-reoxygenation on small and large coronary artery vessels and endothelial cells (year 3), and lastly delineation of the alternative complement pathways during myocardial ischemia-reperfusion in a pig model, with special emphasis on therapeutic attenuation of C5b-9 mediated injury in vivo.
描述:(改编自申请人的摘要)有

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GREGORY L STAHL其他文献

GREGORY L STAHL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GREGORY L STAHL', 18)}}的其他基金

Innate Immunity and Cardiovascular Function
先天免疫和心血管功能
  • 批准号:
    8234296
  • 财政年份:
    2011
  • 资助金额:
    $ 30.13万
  • 项目类别:
Innate Immunity and Cardiovascular Function
先天免疫和心血管功能
  • 批准号:
    8586247
  • 财政年份:
    2011
  • 资助金额:
    $ 30.13万
  • 项目类别:
Innate Immunity and Cardiovascular Function
先天免疫和心血管功能
  • 批准号:
    8385522
  • 财政年份:
    2011
  • 资助金额:
    $ 30.13万
  • 项目类别:
Innate Immunity and Cardiovascular Function
先天免疫和心血管功能
  • 批准号:
    8122877
  • 财政年份:
    2010
  • 资助金额:
    $ 30.13万
  • 项目类别:
Innate Immunity, Biomarkers and Myocardial Infarction
先天免疫、生物标志物和心肌梗塞
  • 批准号:
    7935403
  • 财政年份:
    2009
  • 资助金额:
    $ 30.13万
  • 项目类别:
Innate Immunity, Biomarkers and Myocardial Infarction
先天免疫、生物标志物和心肌梗塞
  • 批准号:
    7805972
  • 财政年份:
    2009
  • 资助金额:
    $ 30.13万
  • 项目类别:
Core--Demonstration
核心--演示
  • 批准号:
    6952180
  • 财政年份:
    2003
  • 资助金额:
    $ 30.13万
  • 项目类别:
Core--Demonstration
核心--演示
  • 批准号:
    6457036
  • 财政年份:
    2001
  • 资助金额:
    $ 30.13万
  • 项目类别:
INNATE IMMUNITY AND MYOCARDIAL INJURY
先天免疫和心肌损伤
  • 批准号:
    6629053
  • 财政年份:
    2000
  • 资助金额:
    $ 30.13万
  • 项目类别:
Mechanisms of complement induced endothelial dysfunction
补体诱导内皮功能障碍的机制
  • 批准号:
    7676512
  • 财政年份:
    1996
  • 资助金额:
    $ 30.13万
  • 项目类别:

相似海外基金

Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases
特发性肺纤维化和其他进行性纤维化间质性肺疾病中的补体途径激活
  • 批准号:
    10590870
  • 财政年份:
    2023
  • 资助金额:
    $ 30.13万
  • 项目类别:
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
APOE4 依赖性调节脑脊液补体通路激活在阿尔茨海默病的发展过程中
  • 批准号:
    10650372
  • 财政年份:
    2022
  • 资助金额:
    $ 30.13万
  • 项目类别:
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
APOE4 依赖性调节脑脊液补体通路激活在阿尔茨海默病的发展过程中
  • 批准号:
    10871775
  • 财政年份:
    2022
  • 资助金额:
    $ 30.13万
  • 项目类别:
Elucidation of the mechanism of peritoneal dialysis-related peritoneal injury through complement pathway and establishment of novel anti-complement therapy.
通过补体途径阐明腹膜透析相关腹膜损伤的机制并建立新型抗补体疗法。
  • 批准号:
    21K08275
  • 财政年份:
    2021
  • 资助金额:
    $ 30.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
  • 批准号:
    10221291
  • 财政年份:
    2020
  • 资助金额:
    $ 30.13万
  • 项目类别:
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
  • 批准号:
    9886859
  • 财政年份:
    2020
  • 资助金额:
    $ 30.13万
  • 项目类别:
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
  • 批准号:
    10080727
  • 财政年份:
    2020
  • 资助金额:
    $ 30.13万
  • 项目类别:
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
  • 批准号:
    10530710
  • 财政年份:
    2020
  • 资助金额:
    $ 30.13万
  • 项目类别:
Role of classical complement pathway underling glial phenotypes and multiple pathologies in Alzheimer's disease and cerebrovascular disease
经典补体途径在神经胶质表型和多种病理学中在阿尔茨海默病和脑血管疾病中的作用
  • 批准号:
    10256776
  • 财政年份:
    2020
  • 资助金额:
    $ 30.13万
  • 项目类别:
Role of classical complement pathway underling glial phenotypes and multiple pathologies in Alzheimer's disease and cerebrovascular disease
经典补体途径在神经胶质表型和多种病理学中在阿尔茨海默病和脑血管疾病中的作用
  • 批准号:
    10468286
  • 财政年份:
    2020
  • 资助金额:
    $ 30.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了